Crown Equity Holdings Inc., (CRWE)

SMIT, Schmitt Industries, Inc.

** On its first quarter fiscal 2012, SMIT reported that its sales increased $1,067,018, or 44.4%, to $3,471,485 compared to $2,404,467 for the same period last year, with net income of $137,028 or $0.05 per diluted share compared to a net loss of ($112,625) or ($.04) per diluted share in the same period prior year

To view video, read the full article and the disclaimer visit URL http://crweselect.com/26729/stock-alerts/smit-clno-knxa-ttgt-plcm-crwese...

Schmitt Industries, Inc. (NASDAQ:SMIT)

RTI Biologics, Inc. and its subsidiaries produce orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues, and improve surgical outcomes.